About the Report
[250 Pages Report] Dermal fillers are used to rejuvenate different facial areas associated with various functionalities. The rising demand for facelift or face line corrections in various emerging countries is enabling the dermal fillers market growth. The rising demand for minimally invasive facial treatments and growing preference towards minimally invasive cosmetic procedures have been favoring the overall expansion of the market
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for Dermal Fillers Market. The report tracks the global sales of dermal fillers in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the medical device industry in general, and dermal fillers in particular.
What is the Future Outlook for Dermal Fillers Market in Comparison to Historical Pattern?
Dermal fillers are injectable implants often used to give a flawless and rejuvenated facial appearance. Besides this, dermal fillers are often used as anti-ageing methods for reduction of the wrinkles, skin folds, and smoothening of the skin. The U.S. Food and Drug Administration (FDA) has approved dermal fillers for various applications, including restoration and correction of lipoatrophy in people with HIV. Other application of dermal fillers include correction of cheek, reduction of acne scars, and reduction of nasolabial folds.
Diverse applications of dermal fillers in helping to improve an individual’s appeatance have been sustaining growth of the market. According to FMI, dermal fillers market is projected to exhibit 2.9% CAGR between 2021 and 2031.
Launches by some of the leading companies will enable consistent growth in the coming years. For instance, in April 2019, Allergan plc. has added Juvéderm® VOLUX to its portfolio to offer advanced solutions specially formulated for restoring and volume in the chin and jaw area.
What is the Scope for Research and Development in Dermal Fillers Market?
An increasing number of manufacturers are highly investing in research and development (R&D) to develop new and innovative technologies in the field of cosmeticology. This is resulting in the advent of higher quality fillers that would be easier to use and would confer better satisfaction for patients.
The cross-linked hyaluronic acid, derived from non-animal source has been utilized for a long time and is proven to be safe and effective as dermal fillers. Some of the leading players have been launching novel formulations, which will enable growth in the market. For instance, Bohus Biotech, a Swedish company developed an advanced dermal filler formulation with the use of spherification technology, with smooth, spherical particles replacing the traditional structure. These newer product formulations are extremely stable and long-lasting, leading to fewer procedures
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
How is Dermal Fillers Market Gaining from Demand for Minimally Invasive Cosmetic Surgeries?
Globally, customers have been exhibiting increasing preference for minimally invasive procedures for improving their appearance. For instance, the minimally invasive procedures that witnessed the most significant increase including Botulinum Toxin Type A (increased by 3% over 2019), dermal filling with hyaluronic acid (increased by 1% over 2019 ) and non-surgical skin tightening experienced steady growth among others.
Besides this, increasing investment some emerging countries is expected to offer high returns. As per American Society of Plastic Surgeons (ASPS), Brazil had the second largest number of cosmetic procedures with almost 2.3 million procedures conducted in 2018 followed by Mexico (1.0 million), India (0.89 million) and Argentina (0.60 million).
Some of the countries in Asia, Latin America and Africa depend on locally manufactured dermal fillers, which are low priced and sub-optimal in terms of commercial reach and product portfolio offer. This is expected to bode well for the overall market.
How Big is the Opportunity in the U.S?
FMI has forecast North America to remain one of the most lucrative markets throughout the forecast period. Some of the key factors supporting expansion are the region’s high disposable income, excellent spending capacity on cosmetic surgeries, and the presence of leading manufacturers and rising demand for non-surgical procedures in the region. According to preliminary forecasts by Centers for Medicare & Medicaid Services (CMS) Office of the Actuary, the overall healthcare spending is likely to increase at 5.4% between 2019 and 2028, outpacing the country’s GDP by 4.3% in United States.
About16.3 million people underwent minimally invasive cosmetic procedures in the United States in 2019 as per American Society of Plastic Surgeons (ASPS), which implies almost more than quarter of million more procedures in 2019 compared to 2018. While about 5.9 million reconstructive procedures.
High disposable incomea and favourable healthcare policies have created a conducive environment for the dermal fillers market in the U.S. Also the presence of leading players such as Zimmer Biomet Holdings supports growth in the U.S. Strategies undertaken by these companies include product launches and expansion plans, which will continue surging overall expansion in the U.S.
Why Brazil is Expected To Be The Second-Most Lucrative Country In Dermal Fillers Market?
The Brazil dermal fillers market is majorly driven by factors such as the increasing lifestyle-related demands, rising awareness about self-grooming, a high acquisition rate of minimally invasive procedures over traditional procedures, and technological advancements in the minimal invasive dermal fillers market.
According to the International Society of Aesthetic Plastic Surgery report, there were total 1,072,002, non-surgical procedures in Brazil, while the most commonly hyaluronic acid utilization was around 37%, Calcium Hydroxylapatite accounted for 2.8% of the total non-surgical procedure share in 2019.
Innovations Are Key to Succeed in Russia Dermal Fillers Market
Increasing demand for minimally invasive procedures, rising adoption of non-surgical dermal fillers and commercialization of novel interventional solutions are major factors boosting the Russian dermal fillers market. The Russian market for dermal fillers is set to exhibit steady growth over the forecast period. The rising ageing population and high adoption of Non hyaluronic acid-based dermal fillers are expect to boost the dermal fillers sales in the country.
Sales in Germany tied closely to New Product Launch and Expansion
New product launch and expansion of the distribution has been enabling growth in the Germany market. For instance, In April 2019, Merz added a new dermal product to its portfolio a “Belotero Revive” dermal filler formulated by the unique combination of hyaluronic acid and glycerol to provide skin solution and improve the skin hydration, reducing its redness and roughness and minimize the appearance of fine lines.
Why is Dermal Fillers Sale Increasing Rapidly in Malaysia?
Medical tourism in Malaysia has been thriving. As per the Malaysia Healthcare Travel Council, the country welcomed 921,000 foreign patients in 2016. Foreign patients from across the world, including Singapore, India, Europe, Japan, Australia, and the U.S. are coming to Malaysia seeking various medical helps. Cosmetic surgeries are definitely among top-priority of a significant number of medical tourists to Malaysia.
Solid support from government and formidable private ad public collaborations have been favoring the expansion of dermal fillers market in the country. Besidea this, Malaysia has some of the best-in-class medical centers and hospitals, which has made it a highly sought-after destination for medical tourists. This has in turn presented lucrative opportunities for dermal filler sellers.
Why Absorbable Dermal Fillers hold the largest share?
The absorbable dermal fillers segment will continue accounting for more than 99% of the global share among products through the forecast period. According to FMI, the segment is expected to hold a little below 100% of the market, in terms of product type, by the end of 2031.
Absorbable dermal fillers are known as the temporary fillers used to treat moderate to severe facial wrinkles and skin folds, such as nasolabial folds (wrinkle lines extending from the sides of the nose to the lips border) and perioral lines (small wrinkles around the mouth and lips). It is a highly demanded filler type owing to its biodegradable properties along with high water retention capacity with the maximum binding site offering better clinical outcomes and high level of patient compliance.
Why is Aesthetic Restoration Highly Preferred in Dermal Fillers Market?
The aesthetic reconstructive application gained high share in the dermal fillers market owing to the high adoption of dermal fillers in the aesthetic reconstructive surgeries owing to its long-term efficacy. Manufacturers are actively focusing on the advancement in the dermal fillers owing to its growing advancement in the reconstructive surgery and surge demand for dermal fillers in the market.
Why is Hyaluronic Acid Based Dermal Fillers in High Demand?
The cross-linked hyaluronic acid ingredient derived from non-animal sources has been proven to be one of the effective and useful dermal fillers owing to its biodegradable properties and safety profile. Hyaluronic acid demand is growing at CAGR of 3.0% and it is expected to reach value of US$ 4,774.1 Mn by the end of 2021.
Which is More Preferred Distribution Channel for Dermal Fillers?
Clinics and hospital pharmacies are more preferred chanel of distribution in the market. FMI has forecast the segment to continue accounting for over half of dermal filler sales recorded worldwide.
Companies operating in the dermal fillers market are aiming at strategic collaborations and acquisitions with the leading pharmaceutical companies to address the requirements of an expanding patient pool. For instance, in Jan 2019, Suneva Medical signed collaborative agreements with Healeon Medical and Bimini Technologies intending to shape the future of regenerative aesthetics sector and expand the sales of the aesthetic products. The company has built the success of Bellafill, the flagship brand, that was the first regenerative product and the longest-lasting dermal filler in the leading dermal fillers market.
Some of the companies are focusing on innovations and USFDA approvals to increase sales of dermal fillers market worldwide. For instance, U.S. FDA approved Galderma’s first hyaluronic acid filler Restylane® Kysse, used for various applications including upper perioral rhytids (wrinkles around upper lips) correction or lip augmentation.
Other than these strategies, key players are focusing on acquisitions and expansion of their global footprint as they await approvals from international organizations For instance, in May 2020, Anika Therapeutics acquired Parcus Medical, and Arthrosurface, a provider of the joint surface and preservation solutions for an active patient to hold its leading position in the aesthetic market, in Jan 2020.
Some of the leading companies operating in the market are:
- Galderma Pharma S.A
- Sinclair Pharma plc
- Zimmer Biomet Holdings
- Allergan plc.
- Anika Therapeutics Inc.
- Merz Pharma GmbH & Co. KGaA
- Suneva Medical Inc.
- Teoxane Laboratories Inc.
- Prollenium Medical Technologies Inc.
- Laboratoires Vivacy SAS
- Fidia Pharma USA Inc.
The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.
Scope of the Report
Historical Data Available for
USD Million for value and Units for Volume
Key Regions Covered
North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa
Key Countries Covered
US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa
Key Segments Covered
Product, Ingredient, Application, Distribution Channel, and Region
Key Companies Profiled
Market Forecast, brand share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing
Key Questions Answered in the Report
Q1. Which is the most lucrative market for dermal fillers market?
North America currently leads the global market for dermal fillers. Within North America, the U.S. will continue exhibiting high demand for dermal fillers.
Q2. Which are the top-selling dermal fillers?
Hyaluronic acid fillers are highly sought-after in every market. The demand for hyaluronic acid is expected to remain high in the near future, especially based on its safety profile and the biodegradable property.
Q3. Which are some of the leading companies offering dermal fillers?
Some of the leading companies offering respiratory inhaler devices are Galderma Pharma S.A, Sinclair Pharma plc, Zimmer Biomet Holdings, Allergan plc, Anika Therapeutics Inc., Merz Pharma GmbH & Co. KGaA, Suneva Medical Inc., Teoxane Laboratories Inc., Prollenium Medical Technologies Inc., Laboratoires Vivacy SAS, Fidia Pharma USA Inc., among others.
Q4. Which distribution channel accounts larger sales of dermal fillers market?
Clinics and hospital pharmacies has been exhibiting high demand for dermal fillers. The segment constitutes half of the total market revenue. Their dominance is owing to availability and supply of a comprehensive range of dermal fillers, which ensures clinics are fully prepared for all patient for cosmetic and aesthetic medicinal procedures.
Enquiry before Buying
- Is this research conducted by Future Market Insights?
Yes, the research has been conducted by expert analysts of Future Market Insights through a combination of primary research and secondary research. To know more about how the research was conducted, you can speak to research analyst.
- What research methodology is followed by FMI?
FMI follows a methodology that encompasses demand side assessment of the market, and triangulates the same through supply side analysis. This methodology is based on use of standard market structure, methods and definitions. Request detailed methodology
- Who are the respondents for primary research?
FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. For a full list of primary respondents, please reach out to us.
- What are the sources of secondary research?
FMI conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
- Is a sample of this report available for evaluation?
Yes, you can request a sample and it will be sent to you through an email.
- How can I buy this report?
FMI provides a secure online payment system to buy report seamlessly. You can buy the report securely and safely.
- Hyaluronic Acid
- Poly-L-Lactic Acid
- Calcium Hydroxylapatite
- Polymethyl methacrylate
- Aesthetic Restoration
- Reconstructive Surgery
- Retail Pharmacies and Drug Stores
- Clinics and Hospital Pharmacies
- Online Pharmacies
- North America
- Latin America
- East Asia
- South Asia
- Middle East and Africa (MEA)